Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial (SALOME)

Original research
par
Oviedo-Joekes, Eugenia et al

Date de publication

2016

Géographie

Canada

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

L’objectif

To test if injectable hydromorphone hydrochloride is noninferior to injectable diacetylmorphine in reducing illicit heroin use for chronic injection opioid users after 6 months of intervention.

Constatations/points à retenir

Conclusions and Relevance  This study provides evidence to suggest noninferiority of injectable hydromorphone relative to diacetylmorphine for long-term opioid dependence. In jurisdictions where diacetylmorphine is currently not available or for patients in whom it is contraindicated or unsuccessful, hydromorphone could be offered as an alternative.

La conception ou méthodologie de recherche

n=202, double blind. Participants were randomly assigned to receive injectable diacetylmorphine or hydromorphone (up to 3 times daily) for 6 months under supervision.

Mots clés

Evidence base
Policy/Regulatory
Safer supply
Advocacy
About prescribers
Outcomes
Illegal drugs
Substitution/OAT